Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease

MLA

Halvard Bonig, et al. “Correction: Real‑world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC‑FFM in Ruxolitinib‑refractory Acute Graft‑versus‑host Disease.” Journal of Translational Medicine, vol. 22, no. 1, June 2024, pp. 1–2. EBSCOhost, https://doi.org/10.1186/s12967-024-05348-8.

APA

Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa‑Marie Pfeffermann, Bernd Jahrsdörfer, Hubert Schrezenmeier, Selim Kuci, Zyrafete Kuci, … Peter Bader. (2024). Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease. Journal of Translational Medicine, 22(1), 1–2. https://doi.org/10.1186/s12967-024-05348-8

Chicago

Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, et al. 2024. “Correction: Real‑world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC‑FFM in Ruxolitinib‑refractory Acute Graft‑versus‑host Disease.” Journal of Translational Medicine 22 (1): 1–2. doi:10.1186/s12967-024-05348-8.